Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes of drugs of abuse, including nicotine, alcohol, opioids, psychostimulants, and hallucinogens, drug-environment interactions, neurochemical mechanisms and medications developments. This volume updates the field of behavioral pharmacology based on new knowledge gained in the past decade.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. xiii 7. Chapter One: Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects - p. 1 8. Chapter Two: In vitro and in vivo pharmacology of kratom - p. 35 9. Chapter Three: Human behavioral pharmacology of stimulant drugs: An update and narrative review - p. 77 10. Chapter Four: Human behavioral pharmacology of psychedelics - p. 105 11. Chapter Five: Stimulus functions of nicotine - p. 133 12. Chapter Six: The incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption - p. 171 13. Chapter Seven: Environmental influence on the preclinical evaluation of substance use disorder therapeutics - p. 219 14. Chapter Eight: Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals - p. 243 15. Chapter Nine: Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond - p. 290 16. Chapter Ten: Potential therapeutic targets for the treatment of opioid abuse and pain - p. 335 17. Chapter Eleven: Trace amine-associated receptor 1 and drug abuse - p. 379 18. Chapter Twelve: Substance abuse and neurotransmission - p. 403
Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes of drugs of abuse, including nicotine, alcohol, opioids, psychostimulants, and hallucinogens, drug-environment interactions, neurochemical mechanisms and medications developments. This volume updates the field of behavioral pharmacology based on new knowledge gained in the past decade.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. xiii 7. Chapter One: Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects - p. 1 8. Chapter Two: In vitro and in vivo pharmacology of kratom - p. 35 9. Chapter Three: Human behavioral pharmacology of stimulant drugs: An update and narrative review - p. 77 10. Chapter Four: Human behavioral pharmacology of psychedelics - p. 105 11. Chapter Five: Stimulus functions of nicotine - p. 133 12. Chapter Six: The incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption - p. 171 13. Chapter Seven: Environmental influence on the preclinical evaluation of substance use disorder therapeutics - p. 219 14. Chapter Eight: Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals - p. 243 15. Chapter Nine: Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond - p. 290 16. Chapter Ten: Potential therapeutic targets for the treatment of opioid abuse and pain - p. 335 17. Chapter Eleven: Trace amine-associated receptor 1 and drug abuse - p. 379 18. Chapter Twelve: Substance abuse and neurotransmission - p. 403
